Laserfiche WebLink
<br />15 <br />government program is not a source of payment. Section 144.6521 of the Minnesota Statutes requires any health care <br />provider with a financial or economic interest in, or an employment or contractual arrangement that limits referral <br />options with, a hospital, outpatient surgical center, or diagnostic imaging facility, or an affiliate, from referring patients <br />to that entity without a written disclosure of such economic interest. While the Corporation does not believe that it is <br />involved in any activities that pose a risk of sanctions under the Provider Conflict of Interest Law, there can be no <br />assurance that such challenge or investigation will not occur in the future. <br />Federal Anti-Kickback Laws. The Federal Medicare/Medicaid Anti-Fraud and Abuse Amendments to the <br />Social Security Act (the “Anti-Kickback Law”) make it a criminal felony offense (subject to certain exceptions) to <br />knowingly or willfully offer, pay, solicit or receive, remuneration in order to induce business (among other <br />prohibitions) for which reimbursement may be provided under a Federal health care programs. The arrangements <br />prohibited under the Anti-Kickback Law can involve hospitals, physicians and other health care providers such as <br />nursing facilities. Prohibited arrangements may include joint ventures between providers, space and equipment <br />rentals, purchases of physician practices, physician recruiting programs and management and personal services <br />contracts. In addition to criminal penalties, violations of the Anti-Kickback Law can lead to FCA liability (as defined <br />below) and exclusion from the Federal health care programs for not less than five years. Exclusion of the Project from <br />Federal health care programs would have a material adverse impact on the operations and financial condition of the <br />Project. <br />As of January 2021, the DHHS Office of Inspector General finalized a new rule regarding the Anti-Kickback <br />Law. The new final rule includes three new safe harbors related to value-based healthcare arrangements. As a result <br />of this final rule, the Office of Inspector General will not impose Anti-Kickback Law-related penalties on entities <br />engaged in compliant care coordination arrangements, value-based arrangements with substantial downside financial <br />risk or value-based arrangements with full financial risk borne by providers. New safe harbors also address new patient <br />engagement models, advanced technology and ACO beneficiary incentives. Finally, the final rule revised the <br />applicability of existing Anti-Kickback Law safe harbors. The final rule constitutes a substantial overhaul to existing <br />Anti-Kickback Law safe harbor regulations. It is not yet known the extent to which the final rule, and resultant <br />implementation, will impact reimbursement arrangements applicable to the Project. <br />False Claims Act. The federal False Claims Act (“FCA”) prohibits (1) knowingly submitting a false or <br />fraudulent claim for payment to the United States; (2) knowingly making, using or causing to be made or used a false <br />record or statement to obtain payment from the United States; or (3) engaging in a conspiracy to defraud the federal <br />government by getting a false or fraudulent claim allowed or paid. This statute is violated if a person acts with actual <br />knowledge, or in deliberate ignorance or reckless disregard of the falsity of the claim. Penalties under the FCA include <br />fines per violation, plus treble damages, potentially resulting in penalties aggregating millions of dollars for ongoing <br />claims submission errors. Anyone who knowingly makes a false statement or representation in any claim to the <br />Medicare or Medicaid programs may be subject to criminal penalties, including fines and imprisonment. <br />The FCA includes “whistleblower” provisions under which a person who believes that someone is violating <br />the FCA can file a sealed complaint against the alleged violator in the name of the United States government. The <br />nature of the allegations is not revealed to the target during the time the United States Justice Department investigates <br />the complaint and determines whether to join in the suit. If the Justice Department decides not to join in the suit, the <br />original whistleblower nonetheless can proceed. If the case is successful, the whistleblower is entitled to between <br />15% and 30% of the proceeds of any fines or damages paid. Although the FCA has been in effect for many years, in <br />recent years there has been a significant increase in the number of whistleblower allegations filed under the FCA, a <br />large number of which involve the health care industry. In 2009, former President Obama signed into law the Fraud <br />Enforcement Recovery Act which authorized increased funding for fraud investigation and prosecution, and expanded <br />the scope of the FCA to impose liability for false claims with more remote connections to the federal government. <br />Billing and Reimbursement Practices. Health care providers, including nursing facilities, also are subject to <br />criminal, civil and exclusionary penalties for violating billing and reimbursement standards under state and federal <br />law. In recent years, state and federal enforcement authorities, in addition to whistleblowers, have investigated and <br />prosecuted providers for submitting false claims to Medicare or Medicaid for services not rendered or for <br />misrepresenting the level or necessity of services actually rendered in order to obtain a higher level of reimbursement. <br />Violations of billing and reimbursement standards can lead to, but is not limited to, FCA liability and a risk of large <br />Medicare/Medicaid repayment obligations.